JP2023553414A5 - - Google Patents
Info
- Publication number
- JP2023553414A5 JP2023553414A5 JP2023534245A JP2023534245A JP2023553414A5 JP 2023553414 A5 JP2023553414 A5 JP 2023553414A5 JP 2023534245 A JP2023534245 A JP 2023534245A JP 2023534245 A JP2023534245 A JP 2023534245A JP 2023553414 A5 JP2023553414 A5 JP 2023553414A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- membered
- group
- compound
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063124695P | 2020-12-11 | 2020-12-11 | |
| US63/124,695 | 2020-12-11 | ||
| PCT/US2021/062850 WO2022125925A1 (en) | 2020-12-11 | 2021-12-10 | Compositions for treating dry age-related macular degeneration (amd) |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023553414A JP2023553414A (ja) | 2023-12-21 |
| JP2023553414A5 true JP2023553414A5 (cg-RX-API-DMAC7.html) | 2024-12-13 |
Family
ID=81974688
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023534245A Pending JP2023553414A (ja) | 2020-12-11 | 2021-12-10 | ドライ型加齢黄斑変性症(amd)治療用組成物 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240009168A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4259129A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023553414A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230118158A (cg-RX-API-DMAC7.html) |
| CN (1) | CN116867488A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021396380A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3200346A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL303592A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023006677A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022125925A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015116923A1 (en) | 2014-01-31 | 2015-08-06 | Cognition Therapeutics, Inc. | Isoindoline compositions and methods for treating neurodegenerative disease |
| ES3063712T3 (en) | 2017-05-15 | 2026-04-20 | Cognition Therapeutics Inc | Compositions for treating neurodegenerative diseases |
| ES2969373B2 (es) | 2022-10-14 | 2025-02-06 | Igen Biolab Group Ag | Composicion obtenida de lisados de microorganismos probioticos para uso en el tratamiento y/o prevencion de las enfermedades degenerativas del ojo |
| WO2025122753A2 (en) * | 2023-12-08 | 2025-06-12 | Cognition Therapeutics, Inc. | Compositions and methods for the treatment of niemann-pick disease |
| CN117945980A (zh) * | 2024-01-24 | 2024-04-30 | 上海健康医学院 | 一种异吲哚硫亚胺类化合物及其制备和作为sigma-2受体抑制剂的应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7776907B2 (en) * | 2002-10-31 | 2010-08-17 | Celgene Corporation | Methods for the treatment and management of macular degeneration using cyclopropyl-N-{2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-3-oxoisoindoline-4-yl}carboxamide |
| EP1635805A4 (en) * | 2003-06-12 | 2007-08-08 | Ms Science Corp | SIGMA RECEPTOR LIGANDS FOR NEURONAL REGENERATION AND FUNCTIONAL RE-ESTABLISHMENT |
| US7829562B2 (en) * | 2003-06-12 | 2010-11-09 | M's Science Corporation | Sigma ligands for neuronal regeneration and functional recovery |
| GB0718737D0 (en) * | 2007-09-25 | 2007-11-07 | Glaxo Group Ltd | Antibodies |
| BRPI0919920A2 (pt) * | 2008-10-22 | 2016-02-16 | Acucela Inc | compostos para tratamento de doenças e desordens oftálmicas |
| US20110269779A1 (en) * | 2008-11-18 | 2011-11-03 | Intellikine, Inc. | Methods and compositions for treatment of ophthalmic conditions |
| US20140378460A1 (en) * | 2011-08-25 | 2014-12-25 | Cognition Therapeutics, Inc. | Compositions and methods for treating neurodegenerative disease |
| WO2015116923A1 (en) * | 2014-01-31 | 2015-08-06 | Cognition Therapeutics, Inc. | Isoindoline compositions and methods for treating neurodegenerative disease |
| ES3063712T3 (en) * | 2017-05-15 | 2026-04-20 | Cognition Therapeutics Inc | Compositions for treating neurodegenerative diseases |
| KR20220142477A (ko) * | 2020-02-13 | 2022-10-21 | 카그니션 테라퓨틱스, 인코퍼레이티드 | 인지 저하 환자에서 아밀로이드 베타 단량체 수준을 감소시키는 방법 |
-
2021
- 2021-12-10 CN CN202180091728.8A patent/CN116867488A/zh active Pending
- 2021-12-10 IL IL303592A patent/IL303592A/en unknown
- 2021-12-10 MX MX2023006677A patent/MX2023006677A/es unknown
- 2021-12-10 WO PCT/US2021/062850 patent/WO2022125925A1/en not_active Ceased
- 2021-12-10 AU AU2021396380A patent/AU2021396380A1/en active Pending
- 2021-12-10 US US18/253,071 patent/US20240009168A1/en active Pending
- 2021-12-10 JP JP2023534245A patent/JP2023553414A/ja active Pending
- 2021-12-10 KR KR1020237023169A patent/KR20230118158A/ko active Pending
- 2021-12-10 CA CA3200346A patent/CA3200346A1/en active Pending
- 2021-12-10 EP EP21904483.1A patent/EP4259129A4/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017507122A5 (cg-RX-API-DMAC7.html) | ||
| JP2024510249A5 (cg-RX-API-DMAC7.html) | ||
| RU2477723C2 (ru) | Ингибиторы протеинкиназ (варианты), их применение для лечения онкологических заболеваний и фармацевтическая композиция на их основе | |
| RU2010136665A (ru) | Новые пиридиноны и пиридазиноны | |
| JP2012530765A5 (cg-RX-API-DMAC7.html) | ||
| RU2419626C2 (ru) | Соединения и композиции в качестве ингибиторов протеазы, активирующей каналы | |
| RU2015106605A (ru) | Соединения замещенных пиразолонов и способы использования | |
| RU2010145463A (ru) | Производные замещенного 2-фенилпиридина | |
| RU2009115653A (ru) | Производные 5-замещенного хиназолинона, содержащие их композиции и способы их применения | |
| RU2008126245A (ru) | Комбинация ингибитора асне и антагониста 5-нт для лечения когнитивной дисфункции | |
| RU2009148673A (ru) | Производные пиразинона и их применение для лечения легочных заболеваний | |
| JP2023552610A5 (cg-RX-API-DMAC7.html) | ||
| JP2016509591A5 (cg-RX-API-DMAC7.html) | ||
| AR086972A1 (es) | Procesos para preparar compuestos heterociclicos, que incluyen trans-7-oxo-6-(sulfooxi)-1,6-diazabiciclo[3,2,1]octano-2-carboxamida y sales de la misma | |
| JP2010538076A5 (cg-RX-API-DMAC7.html) | ||
| RU2013108641A (ru) | Способ лечения офтальмологических заболеваний с использованием соединений ингибиторов киназы в пролекарственных формах | |
| JP2014508720A5 (cg-RX-API-DMAC7.html) | ||
| RU2007148217A (ru) | Получение производных n-фенил-2-пиримидинамина | |
| JP2013525458A5 (cg-RX-API-DMAC7.html) | ||
| JP2007502804A5 (cg-RX-API-DMAC7.html) | ||
| JP2022533939A5 (cg-RX-API-DMAC7.html) | ||
| AR063804A1 (es) | Compuestos de azoniabiciclo[2.2.2]octano | |
| JP2004520282A5 (cg-RX-API-DMAC7.html) | ||
| JP2013539786A5 (cg-RX-API-DMAC7.html) | ||
| AR054787A1 (es) | Derivados de piperidinas utiles como antagonistas de histamina h3 |